PFKFB4
6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 4
Also known as: F264_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q16877
- Gene
- PFKFB4
- Ensembl
- ENSG00000114268
- Chromosome
- 3
- Canonical length
- 469 aa
- Protein class
- Enzymes, Metabolic proteins, Predicted intracellular proteins
- Subcellular location
- Nucleoli
- Quaternary structure
- Homodimer
OverviewNCBI Gene
The protein encoded by this gene is one of four bifunctional kinase/phosphatases that regulate the concentration of the glycolytic byproduct fructose-2,6-bisphosphate (F2,6BP). The encoded protein is highly expressed in cancer cells and is induced by hypoxia. This protein is essential to the survival of cancer cells under conditions of hypoxia, because it increases the amount of F2,6BP and ATP at a time when the cell cannot produce much of them. This finding suggests that this protein may be a good target for disruption in cancer cells, hopefully imperiling their survival. Several transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Nov 2015]
Canonical amino-acid sequenceUniProt
469 residues, UniProt reviewed canonical sequence.
>Q16877|PFKFB4
1 MASPRELTQN PLKKIWMPYS NGRPALHACQ RGVCMTNCPT LIVMVGLPAR GKTYISKKLT
61 RYLNWIGVPT REFNVGQYRR DVVKTYKSFE FFLPDNEEGL KIRKQCALAA LRDVRRFLSE
121 EGGHVAVFDA TNTTRERRAT IFNFGEQNGY KTFFVESICV DPEVIAANIV QVKLGSPDYV
181 NRDSDEATED FMRRIECYEN SYESLDEDLD RDLSYIKIMD VGQSYVVNRV ADHIQSRIVY
241 YLMNIHVTPR SIYLCRHGES ELNLKGRIGG DPGLSPRGRE FAKSLAQFIS DQNIKDLKVW
301 TSQMKRTIQT AEALGVPYEQ WKVLNEIDAG VCEEMTYEEI QDNYPLEFAL RDQDKYRYRY
361 PKGESYEDLV QRLEPVIMEL ERQENVLVIC HQAVMRCLLA YFLDKAAEQL PYLKCPLHTV
421 LKLTPVAYGC KVESIFLNVA AVNTHRDRPQ NVDISRPPEE ALVTVPAHQLocalizationUniProt · AlphaFold · HPA
Whether an antibody against PFKFB4 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.25
- Highest tissue expression
- 24 nTPM
Expression across tissuesHPA
Tissue
- testis: 24 nTPM
- small intestine: 20 nTPM
- duodenum: 17 nTPM
- epididymis: 17 nTPM
- retina: 15 nTPM
- bone marrow: 14 nTPM
Single-cell type
- neutrophils: 249 nCPM
- sertoli cells: 178 nCPM
- enterocytes: 112 nCPM
- extravillous trophoblasts: 105 nCPM
- neutrophil progenitors: 102 nCPM
- epididymal basal cells: 82 nCPM
Immune cell
- neutrophil: 41 nTPM
- non-classical monocyte: 25 nTPM
- eosinophil: 22 nTPM
- intermediate monocyte: 14 nTPM
- classical monocyte: 13 nTPM
- myeloid DC: 5.2 nTPM
Brain region
- thalamus: 14 nTPM
- cerebral cortex: 12 nTPM
- pons: 12 nTPM
- medulla oblongata: 11 nTPM
- white matter: 11 nTPM
- midbrain: 11 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.96
- gnomAD pLI
- 0
- gnomAD missense Z
- 1.36
- DepMap mean gene effect
- -0.23
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- fructose 2,6-bisphosphate metabolic process
- fructose metabolic process
- gluconeogenesis
- glycolytic process
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Phosphoglycerate/bisphosphoglycerate mutase, active site
- Fructose-2,6-bisphosphatase
- Histidine phosphatase superfamily, clade-1
- 6-phosphofructo-2-kinase
- P-loop containing nucleoside triphosphate hydrolase
- Histidine phosphatase superfamily
- Histidine phosphatase superfamily (branch 1)
- 6-phosphofructo-2-kinase
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of PFKFB4 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads PFKFB4 as an antibody target. Whether an autoantibody or antibody against PFKFB4 could matter depends on whether native PFKFB4 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
PFKFB4 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label PFKFB4 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...